VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
39 hedge funds and large institutions have $182M invested in Verona Pharma in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
27% less capital invested
Capital invested by funds: $248M → $182M (-$66.3M)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Holders
39
Holding in Top 10
4
Calls
$79K
Puts
–
Top Buyers
| 1 | +$1.84M | |
| 2 | +$888K | |
| 3 | +$882K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$66K |
| 5 |
Millennium Management
New York
|
+$54.2K |
Top Sellers
| 1 | -$5.26M | |
| 2 | -$673K | |
| 3 | -$82K | |
| 4 |
RG
Rathbones Group
Liverpool,
United Kingdom
|
-$80K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$80K |